# Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis

> **NCT04252625** · PHASE2 · TERMINATED · sponsor: **University of Utah** · enrollment: 10 (actual)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **DRUG:** Q-Urol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04252625
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-14
- **Primary completion:** 2023-12-27
- **Final completion:** 2024-01-25
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Drug Supply Issue
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04252625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04252625, "Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04252625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*